Clinical Trial

Study of DSP-0390 in Patients With Recurrent High-Grade Glioma

Active, Not Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This is a study of DSP-0390 in patients with recurrent high grade glioma.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-09-30 -> 2027-09-30 2026-07-30
minor Completion pushed: 2026-10-31 -> 2027-10-31 2026-07-30
Trial Details
NCT Number NCT05023551
Lead Sponsor Sumitomo Pharma America, Inc.
Conditions High Grade Glioma, Glioblastoma Multiforme
Enrollment 39 participants
Start Date 2021-09-08
Primary Completion 2027-09-30 (estimated)
Study Completion 2027-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-29